TelyRx Holdings Inc. is seeing a notable rise in its stock price, reflecting positive investor sentiment.
TelyRx Holdings Inc. (TELY.TO) is up today, with shares increasing by 4.00% to a closing price of CA$2.60. This surge comes as interest grows in the company's digital pharmacy services, which have recently surpassed one million prescriptions filled.
Investor takeaway: Investors might see TelyRx's recent performance as a sign of increasing confidence in its business model and growth potential.
Advertisement
TelyRx Holdings Inc.
TELY.TO
TELY.TO
TelyRx Holdings Inc.
WealthAwesomeAdvertisement
Market cap
$66.45M
52W high
$4.25
52W low
$2.00
1W change
+1.96%
Analyst Price Targets
Based on analyst covering TELY
Wall Street analysts forecast TELY stock price to rise 130.8% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$6.00
+130.8% Upside
Current Price
C$2.60
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Advertisement
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TELY's historical volatility
30-Day Vol
109.9%
Annualized
90-Day Vol
101.9%
Annualized
Trend (90d)
-31.1%
Annualized drift
90d Mean
C$2.33
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$2.51 | C$1.71 – C$3.66 |
| 60 trading days | C$2.41 | C$1.41 – C$4.13 |
| 90 trading days | C$2.33 | C$1.21 – C$4.49 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
4.00% Increase in Stock Price
TelyRx's stock has experienced a significant 4.00% increase today, indicating a positive shift in market sentiment.
Bull case
The company’s recent announcement of surpassing one million prescriptions shows strong demand for its services. This demand could lead to sustained revenue growth and continued interest from investors.
Bear case
Despite the positive movement, TelyRx is still operating at a loss, and any market volatility could affect its stock performance in the future.
Market Performance
Advertisement
TelyRx Holdings Inc. has seen a 4.00% increase in its stock price today, closing at CA$2.60. This performance reflects a broader trend in the market as investors show increased interest in companies leveraging technology in healthcare.
Growing Demand for Digital Pharmacy
The company recently announced that it has filled over one million prescriptions, highlighting the growing consumer demand for digital pharmacy services. This milestone could be a key driver of TelyRx's stock performance, showcasing the effectiveness of its business model.
Future Outlook
While TelyRx is currently enjoying positive stock movement, investors should stay cautious. The company has yet to achieve profitability, and fluctuations in market conditions could impact its future performance. Keeping an eye on upcoming financial results will be important for assessing its long-term viability.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
